# Effectiveness and Safety of Mesenchymal Stem Cell (MSC) Implantation on Degenerative Discus Disease Patients

> **NCT04499105** · PHASE2 · UNKNOWN · sponsor: **Ahmad Jabir Rahyussalim** · enrollment: 10 (estimated)

## Conditions studied

- Degenerative Disc Disease
- Low Back Pain
- Disc Degeneration

## Interventions

- **DRUG:** Mesenchymal Stem Cell + NaCl 0,9% 2ml

## Key facts

- **NCT ID:** NCT04499105
- **Lead sponsor:** Ahmad Jabir Rahyussalim
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-24
- **Primary completion:** 2020-12
- **Final completion:** 2020-12
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2020-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04499105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04499105, "Effectiveness and Safety of Mesenchymal Stem Cell (MSC) Implantation on Degenerative Discus Disease Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04499105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*